These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15855265)

  • 1. AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors.
    Fassnacht M; Weismann D; Ebert S; Adam P; Zink M; Beuschlein F; Hahner S; Allolio B
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4366-70. PubMed ID: 15855265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas.
    Ilvesmäki V; Liu J; Heikkilä P; Kahri AI; Voutilainen R
    Horm Metab Res; 1998 Oct; 30(10):619-23. PubMed ID: 9851669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
    Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
    J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
    Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
    Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
    Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
    Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.
    Liu J; Voutilainen R; Kahri AI; Heikkilä P
    J Endocrinol; 1997 Feb; 152(2):175-81. PubMed ID: 9071974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent activation of AKT2 kinase in human pancreatic carcinomas.
    Altomare DA; Tanno S; De Rienzo A; Klein-Szanto AJ; Tanno S; Skele KL; Hoffman JP; Testa JR
    J Cell Biochem; 2002; 87(4):470-6. PubMed ID: 14735903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN-mediated Akt activation in human neocortex during prenatal development.
    Tanriover G; Demir N; Pestereli E; Demir R; Kayisli UA
    Histochem Cell Biol; 2005 Jun; 123(4-5):393-406. PubMed ID: 15889265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas.
    Ilvesmäki V; Kahri AI; Miettinen PJ; Voutilainen R
    J Clin Endocrinol Metab; 1993 Sep; 77(3):852-8. PubMed ID: 8370710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.
    Oki E; Baba H; Tokunaga E; Nakamura T; Ueda N; Futatsugi M; Mashino K; Yamamoto M; Ikebe M; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Nov; 117(3):376-80. PubMed ID: 15900596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.
    Zeng Z; Zhou Z; Zhan N; Yuan J; Ye B; Gu L; Wang J; Jian Z; Xiong X
    Endocr Pathol; 2015 Dec; 26(4):302-8. PubMed ID: 26555087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.